Tempus AI Total Common and Preferred Stock Dividends Paid 2023-2025 | TEM

Tempus AI annual/quarterly total common and preferred stock dividends paid history and growth rate from 2023 to 2025. Total common and preferred stock dividends paid can be defined as the cash outflow for all company dividends paid out to preferred and common shareholders.
  • Tempus AI total common and preferred stock dividends paid for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Tempus AI total common and preferred stock dividends paid for the twelve months ending March 31, 2025 were $-0.017B, a 0% increase year-over-year.
  • Tempus AI annual total common and preferred stock dividends paid for 2024 were $-0.006B, a 0% decline from 2023.
  • Tempus AI annual total common and preferred stock dividends paid for 2023 were $-0.006B, a 0% decline from 2022.
  • Tempus AI annual total common and preferred stock dividends paid for 2022 were $-0.006B, a 0% decline from .
Tempus AI Annual Total Common and Preferred Stock Dividends Paid
(Millions of US $)
2024 $-6
2023 $-6
2022 $-6
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.826B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.769B 58.23
Hims & Hers Health (HIMS) United States $14.374B 149.35
Doximity (DOCS) United States $10.774B 49.88
IRhythm Technologies (IRTC) United States $4.653B 0.00
Inspire Medical Systems (INSP) United States $3.861B 60.33
Hinge Health (HNGE) United States $3.282B 0.00
Privia Health (PRVA) United States $2.664B 182.08
Enovis (ENOV) United States $1.720B 9.59
Phreesia (PHR) United States $1.560B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Schrodinger (SDGR) United States $1.501B 0.00
Azenta (AZTA) United States $1.357B 63.06
10x Genomics (TXG) United States $1.331B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Evolent Health (EVH) United States $1.086B 92.50
Claritev (CTEV) United States $0.657B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.448B 134.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.337B 746.67
Outset Medical (OM) United States $0.336B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.156B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
CareCloud (CCLD) United States $0.106B 4.03
Pulmonx (LUNG) United States $0.105B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.094B 0.00
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00